levodopa has been researched along with Depression, Involutional in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (66.67) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Bekhbat, M; Felger, JC; Haroon, E; Li, Z; Lucido, MJ; Mehta, ND; Miller, AH; Treadway, MT; Woolwine, BJ | 1 |
| Jiang, MD; Wang, JL; Wang, YF; Zheng, Y | 1 |
| Abi-Dargham, A; Bailey, V; Brown, PJ; Chen, C; Roose, SP; Rutherford, BR; Slifstein, M; Stern, Y; Valente, E; Vanegas-Arroyave, N; Wall, MW | 1 |
| Chung, SJ; Shin, HW; Sohn, YH; Youn, YC | 1 |
| Byrne, GJ; Dissanayaka, NN; Marsh, R; Matheson, S; Mellick, GD; O'Sullivan, JD; Sellbach, A; Silburn, PA | 1 |
| Ito, H; Ito, S; Kuroda, Y; Motohashi, N; Nishikawa, T; Suhara, T; Takahashi, H; Takano, A | 1 |
| Czernecki, V; Dubois, B; Houeto, JL; Levy, R; Pillon, B; Pochon, JB | 1 |
| Ardouin, C; Benabid, AL; Fraix, V; Funkiewiez, A; Krack, P; Moro, E; Pollak, P; Van Blercom, N; Xie, J | 1 |
| Bakay, RA; Barnhart, H; Chockkan, V; DeLong, MR; Evatt, M; Freeman, A; Green, J; Haber, M; McDonald, W; Mewes, K; Triche, S; Vitek, JL; Wahlay, N; Zhang, JY | 1 |
| Esel, E; Kartalci, S; Sofuoglu, S; Turan, T; Tutus, A | 1 |
| Derejko, M; Friedman, A; Sławek, J; Zach, M | 1 |
| Araujo Silva, MT; Barbosa, ER; Bermpohl, F; Boggio, PS; Fregni, F; Mansur, CG; Marcolin, MA; Odebrecht Rosa, M; Pascual-Leone, A; Rigonatti, SP; Rosa, M; Rumi, DO | 1 |
| Baltuch, GH; Chou, KL; Hurtig, HI; Jaggi, JL; Pelchat, RJ; Weintraub, D | 1 |
| Lennox, G; Misbahuddin, A; Placzek, M; Taanman, JW; Warner, TT | 1 |
| Alvarez, C; Andreatini, R; da Silva, TM; Ferraz, AC; Kiss, A; Munhoz, RP; Naliwaiko, K | 1 |
| Mahowald, MW; Schenck, CH | 1 |
| Bilbao Garay, J; Castilla Castellano, V; Dhimes Tejada, P; Mesa Plaza, N | 1 |
2 review(s) available for levodopa and Depression, Involutional
| Article | Year |
|---|---|
Treatment of depression in idiopathic Parkinson's disease.
Topics: Antidepressive Agents; Antiparkinson Agents; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2002 |
[Serotonin syndrome: report of a fatal case and review of the literature].
Topics: Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder, Major; Drug Combinations; Drug Synergism; Fatal Outcome; Fluoxetine; Humans; Levodopa; Male; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Syndrome | 2002 |
7 trial(s) available for levodopa and Depression, Involutional
| Article | Year |
|---|---|
Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study.
Topics: Adult; Anhedonia; Depression; Depressive Disorder, Major; Dopamine; Humans; Inflammation; Levodopa; Magnetic Resonance Imaging; Neural Pathways; Reward | 2022 |
Effects of L-DOPA Monotherapy on Psychomotor Speed and [
Topics: Aged; Aged, 80 and over; Carbidopa; Corpus Striatum; Depressive Disorder, Major; Dopamine; Dopamine Antagonists; Drug Combinations; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; New York; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Walking Speed | 2019 |
Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Single-Blind Method; Statistics, Nonparametric; Transcranial Magnetic Stimulation; Treatment Outcome | 2016 |
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
Topics: Antiparkinson Agents; Atrophy; Brain; Carbidopa; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Severity of Illness Index; Treatment Outcome; Tremor | 2003 |
Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
Topics: Adult; Antidepressive Agents; Chi-Square Distribution; Depressive Disorder, Major; Dexamethasone; Drug Interactions; Female; Growth Hormone; Humans; Hydrocortisone; Levodopa; Male; Middle Aged; Pituitary-Adrenal Function Tests; Prolactin; Thyroid Function Tests; Thyrotropin; Thyrotropin-Releasing Hormone | 2004 |
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Functional Laterality; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Periodicity; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Transcranial Magnetic Stimulation | 2005 |
Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
Topics: Aged; Antidepressive Agents; Antiparkinson Agents; Brazil; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Female; Humans; Levodopa; Male; Middle Aged; Mineral Oil; Parkinson Disease; Personality Inventory; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Treatment Outcome | 2008 |
9 other study(ies) available for levodopa and Depression, Involutional
| Article | Year |
|---|---|
Drug induces depression-like phenotypes and alters gene expression profiles in Drosophila.
Topics: Animals; Chlorpromazine; Depressive Disorder, Major; Disease Models, Animal; Dose-Response Relationship, Drug; Drosophila melanogaster; Eating; Female; Gene Expression; Levodopa; Male; Malondialdehyde; Maternal Exposure; Paternal Exposure; Serotonin; Sexual Behavior, Animal; Superoxide Dismutase | 2017 |
Anxiety disorders in Parkinson's disease: prevalence and risk factors.
Topics: Aged; Antiparkinson Agents; Anxiety Disorders; Cognition Disorders; Comorbidity; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Functional Laterality; Gait; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Posture; Prevalence; Risk Factors; Severity of Illness Index | 2010 |
Chronic repetitive transcranial magnetic stimulation failed to change dopamine synthesis rate: preliminary L-[β-11C]DOPA positron emission tomography study in patients with depression.
Topics: Adult; Brain; Carbon Radioisotopes; Depressive Disorder, Major; Dopamine; Female; Humans; Levodopa; Male; Positron-Emission Tomography; Transcranial Magnetic Stimulation | 2010 |
Motivation, reward, and Parkinson's disease: influence of dopatherapy.
Topics: Adult; Antiparkinson Agents; Cognition Disorders; Corpus Striatum; Depressive Disorder, Major; Extinction, Psychological; Female; Frontal Lobe; Humans; Levodopa; Male; Motivation; Nerve Net; Neuropsychological Tests; Parkinson Disease; Reinforcement, Psychology; Reward | 2002 |
Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition Disorders; Depressive Disorder, Major; Electric Stimulation Therapy; Female; Frontal Lobe; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychological Tests; Psychomotor Disorders; Severity of Illness Index; Subthalamic Nucleus; Surveys and Questionnaires; Time | 2003 |
Quality of life in Polish patients with long-lasting Parkinson's disease.
Topics: Activities of Daily Living; Aged; Amantadine; Antiparkinson Agents; Depressive Disorder, Major; Dopamine Agents; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Parkinson Disease; Poland; Quality of Life; Regression Analysis; Socioeconomic Factors; Surveys and Questionnaires; Time Factors | 2004 |
Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators.
Topics: Antiparkinson Agents; Antipsychotic Agents; Deep Brain Stimulation; Depressive Disorder, Major; Dibenzothiazepines; Electroconvulsive Therapy; Female; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Quetiapine Fumarate; Subthalamic Nucleus | 2005 |
Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene.
Topics: Adult; Aged; Antiparkinson Agents; Depressive Disorder, Major; Drug Administration Schedule; Dystonia; Exons; Gene Expression; Humans; Incidence; Levodopa; Male; Myoclonus; Point Mutation; Sarcoglycans | 2007 |
Combined bupropion-levodopa-trazodone therapy of sleep-related eating and sleep disruption in two adults with chemical dependency.
Topics: Adult; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Bupropion; Depressive Disorder, Major; Drug Therapy, Combination; Feeding and Eating Disorders; Female; Humans; Levodopa; Male; Substance-Related Disorders; Trazodone; Wakefulness | 2000 |